Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Arch Med Res ; 44(3): 169-77, 2013 Apr.
Article in English | MEDLINE | ID: mdl-23506720

ABSTRACT

BACKGROUND AND AIMS: The efficacy of a direct application of plasma needle to in vivo wound healing was experimentally studied in mice. This kind of plasma has achieved considerable success in blood coagulation and tissue restoration in mice. In the development of the present study, an argon plasma needle was chosen for coagulation purposes, whereas for healing purposes, a helium plasma needle was used. METHODS: Treatment was applied with a plasma needle produced by argon and helium to a wound induced in laboratory mice. Tissue regeneration was carried out by three argon plasma treatments with 0.5 SLPM flow for 1 min and three treatments of helium with 1.5 SLPM flow. Intervals between each treatment were 5 min and 60 min for argon and helium plasmas, respectively, thus completing a total treatment time of 180 min. Histological sections were performed to corroborate the internal bleeding and tissue regeneration. RESULTS: After three treatments with argon plasma, the blood produced in the wound was coagulated and protein material appeared. By means of treatment with helium plasma, an approach of the wound edges was produced until the conclusion thereof. These results were corroborated histologically. CONCLUSIONS: This type of acceleration during the skin wound healing process can be attributed to the formation of reactive species such as NO, which were increased in the helium plasma needle with respect to the argon plasma needle.


Subject(s)
Argon/pharmacology , Helium/pharmacology , Needles , Plasma Gases/administration & dosage , Plasma Gases/therapeutic use , Skin/drug effects , Wound Healing/drug effects , Acute Disease/therapy , Animals , Argon/administration & dosage , Argon/therapeutic use , Helium/administration & dosage , Helium/therapeutic use , Mice , Nitric Oxide/metabolism , Plasma Gases/pharmacology , Skin Diseases/therapy , Time Factors , Wound Healing/physiology
2.
Am J Trop Med Hyg ; 81(3): 390-5, 2009 Sep.
Article in English | MEDLINE | ID: mdl-19706902

ABSTRACT

Here we describe clinical and pathologic evidence of Chagas disease caused in dogs by circulating Trypanosoma cruzi from a newly recognized endemic area in Mexico. We show that the Zumpahuacan isolate, although less virulent than the Sylvio-X10 reference strain that caused acute myocarditis and death, was pathogenic in dogs. Dogs infected with the Zumpahuacan isolate exhibited electrocardiographic alterations, left- and right-ventricle dilation, and hydropericardium. Histologically, diffused perimysial and endomysial lymphoplasmacytic cell infiltration, cardiomyocyte necrosis, and amastigote nests were noted in Zumpahuacan-infected dogs. These findings suggest that the risk of T. cruzi infection and Chagas disease is present in the State of Mexico, and further research is needed to identify the T. cruzi bio-types circulating in southern State of Mexico.


Subject(s)
Chagas Disease/veterinary , Dog Diseases/parasitology , Trypanosoma cruzi/pathogenicity , Animals , Chagas Cardiomyopathy/epidemiology , Chagas Cardiomyopathy/parasitology , Chagas Cardiomyopathy/veterinary , Chagas Disease/epidemiology , Chagas Disease/parasitology , Chagas Disease/pathology , Disease Models, Animal , Disease Reservoirs/veterinary , Dog Diseases/epidemiology , Dog Diseases/pathology , Dogs , Mexico/epidemiology , Mice , Mice, Inbred BALB C , Myocardium/pathology , Virulence
SELECTION OF CITATIONS
SEARCH DETAIL
...